Product Images Quelicin

This is a warning label for a medication that is intended for intravenous or intramuscular use. The medication contains methylparaben and propylparaben as preservatives. It is a paralyzing agent that can cause respiratory arrest, and artificial respiration equipment must be immediately available. The medication is distributed by Hospira, Inc. and is for prescription use only. The expiration date is also provided.*

This appears to be a description of a medication product in the form of an injection. The medication is called Succinylcholine Chloride Injection, USP, and it is manufactured in Canada. It is intended for intravenous or intramuscular use and is indicated for dosage, precautions, indications and directions for use. This medication is a paralyzing agent and should be stored in a refrigerator at a temperature of 2° to 8°C (36° to 46°F). The text also includes information about the product's packaging, dosage, and manufacturer.*

This is a warning label for Rxonly drug NDC0409-6970-10, which is Succinylcholine Chloride Injection, for intravenous use only. It must be diluted before use and may contain HCl and/or NaOH. It is a paralyzing agent and can cause respiratory arrest, therefore, facilities must be available for artificial respiration. It is a sterile and non-pyrogenic drug that should be stored between 2°C to 8°C. The manufacturer is Hospira, Inc. from Lake Forest, IL in the USA.*

This text is a label for a drug called succinylcholine chloride injection. It warns that the drug is a paralyzing agent that can cause respiratory issues and must be diluted before use. Each mL of the drug contains 100 m of succinylcholine chloride, and it may contain sodium hydroxide and/or hydrochloric acid for pH adjustment. The pH is 36 and the drug is sterile, non-pyrogenic, and for intravenous use. The label provides dosage and administration instructions, NDC number, manufacturer's information and some unreadable characters.*